Related Experiment Video
Updated: May 26, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
The role of the transcription factor SIM2 in prostate cancer
Bin Lu1, John M Asara, Martin G Sanda
1Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
Background:
Recent reports have suggested a possible involvement of Single-minded homolog 2 (SIM2) in human solid cancers, including prostate cancer. However, the exact role of SIM2 in cancer in general, and in prostate cancer in particular, remains largely unknown. This study was designed to elucidate the role of SIM2 in prostate cancer using a shRNA-based approach in the PC3 prostate cancer cell line.
Methods:
Lentiviral shRNAs were used to inhibit SIM2 gene and protein levels in PC3 cells. Quantitative RT-PCR and branched DNA were performed to evaluate transcript expression. SIM2 protein expression level was measured by western blot. Profiling of gene expression spanning the whole genome, as well as polar metabolomics of several major metabolic pathways was performed to identify major pathway dysregulations.
Results:
SIM2 gene and protein products were significantly downregulated by lenti-shRNA in PC3 cell line. This low expression of SIM2 affected gene expression profile, revealing significant changes in major signaling pathways, networks and functions. In addition, major metabolic pathways were affected.
Conclusion:
Taken together, our results suggest an involvement of SIM2 in key traits of prostate tumor cell biology and might underlie a contribution of this transcription factor to prostate cancer onset and progression.
Insights
Single-minded homolog 2 (SIM2) downregulation impacts prostate cancer cell biology. This study reveals SIM2's role in key tumor traits, suggesting its involvement in prostate cancer development and progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Emerging evidence suggests Single-minded homolog 2 (SIM2) involvement in human solid tumors.
- The precise function of SIM2 in cancer, particularly prostate cancer, requires further investigation.
Purpose of the Study:
- To investigate the role of SIM2 in prostate cancer.
- To elucidate SIM2's function in PC3 prostate cancer cells using a shRNA-based knockdown approach.
Main Methods:
- Utilized lentiviral shRNAs to downregulate SIM2 gene and protein expression in PC3 cells.
- Assessed transcript levels via quantitative RT-PCR and branched DNA assays.
- Measured SIM2 protein levels using western blot.
- Performed whole-genome gene expression profiling and polar metabolomics to identify pathway dysregulations.
Main Results:
- Significant downregulation of SIM2 gene and protein was achieved in PC3 cells.
- Reduced SIM2 expression led to altered global gene expression profiles, impacting major signaling pathways, networks, and functions.
- Key metabolic pathways were observably affected by SIM2 downregulation.
Conclusions:
- SIM2 plays a role in critical aspects of prostate tumor cell biology.
- The findings suggest SIM2 may contribute to the initiation and progression of prostate cancer.
Related Concept Videos
Master Transcription Regulators
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
RNA Polymerase II Accessory Proteins
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

